Cellectis (CLLS) Return on Assets [ROA] (2015 - 2026)
Cellectis' Return on Assets [ROA] was -18.06% in Q2 2026, down 1.63 percentage points from -16.43% a year earlier but up 0.92 percentage points from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Cellectis came in at -19.09%, down 8.84 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -9.72 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -10.24% in FY2024 (+26.18 pp), -36.42% in FY2023 (-0.97 pp), -35.45% in FY2022 (-6.07 pp) and -29.38% in FY2021 (-20.01 pp).
- Quarterly Return on Assets [ROA] has moved between -45.50% (Q2 2023) and -9.43% (Q4 2024) over five years.
- Compared with a year earlier, Return on Assets [ROA] has declined for three straight quarters, with an average year-over-year change of +7.14 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2024 (a gain of 30.44 percentage points); the worst was Q1 2022 (a drop of 31.29 percentage points).
- Per Business Quant data, CLLS's Return on Assets [ROA] in the three quarters before Q2 2026 was -18.98% (Q1 2026), -20.24% (Q4 2025) and -10.14% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Cellectis | 151.51 Mn | -601.88 Mn | - | -18.06% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.06% |
| Mar 31, 2026 | -18.98% |
| Dec 31, 2025 | -20.24% |
| Sep 30, 2025 | -10.14% |
| Jun 30, 2025 | -16.43% |
| Mar 31, 2025 | -16.19% |
| Dec 31, 2024 | -9.43% |
| Sep 30, 2024 | -21.04% |
| Jun 30, 2024 | -20.72% |
| Mar 31, 2024 | -20.41% |
| Dec 31, 2023 | -39.87% |
| Sep 30, 2023 | -43.54% |
| Jun 30, 2023 | -45.50% |
| Mar 31, 2023 | -43.62% |
| Dec 31, 2022 | -42.17% |
| Sep 30, 2022 | -37.82% |
| Jun 30, 2022 | -36.63% |
| Mar 31, 2022 | -39.63% |
| Dec 31, 2021 | -31.47% |
| Sep 30, 2021 | -11.56% |
API Access
Cellectis Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();